Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Rigel Pharmaceuticals, Inc. - Common Stock (NQ:RIGL)

42.83 +1.64 (+3.98%)
Streaming Delayed Price Updated: 12:49 PM EST, Jan 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Rigel Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Rigel Pharmaceuticals Inc (NASDAQ:RIGL) Shows Strong Growth and Technical Momentum ↗
Via Chartmill
News headline image
Rigel Pharmaceuticals Inc. (NASDAQ:RIGL) Emerges as a Top Affordable Growth Stock ↗
Rigel Pharmaceuticals (RIGL) presents a strong GARP investment case with high growth, solid profitability, and a notably low valuation compared to its biotech peers. 
Via Chartmill
News headline image
RIGEL PHARMACEUTICALS INC (NASDAQ:RIGL) Presents a Strong 'Decent Value' Investment Case ↗
Rigel Pharmaceuticals (RIGL) presents a strong value investment case with a very low P/E ratio, robust financial health, and high earnings growth potential. 
Via Chartmill
News headline image
RIGEL PHARMACEUTICALS INC (NASDAQ:RIGL) Meets Minervini Trend Template and High-Growth Momentum Criteria ↗
Rigel Pharmaceuticals (RIGL) aligns with Mark Minervini's growth strategy, showing a strong technical uptrend supported by accelerating earnings and revenue momentum. 
Via Chartmill
News headline image
RIGEL PHARMACEUTICALS INC (NASDAQ:RIGL): A GARP Investment with Strong Growth and a Reasonable Price ↗
Discover Rigel Pharmaceuticals (RIGL), a GARP stock with explosive growth, a low P/E ratio, and strong financials, offering value in the biotech sector. 
Via Chartmill
News headline image
Earnings Scheduled For November 4, 2025 ↗
 
Via Benzinga
Rigel Pharmaceuticals Inc (NASDAQ:RIGL) Presents a Compelling Case for Value Investors ↗
Via Chartmill
News headline image
Keep an eye on the top gainers and losers in Wednesday's session. ↗
Curious to know what's happening on the US markets in the middle of the day on Wednesday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Johnson Controls, Babcock & Wilcox, Lemonade, Lumentum, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
Wednesday's session: gap up and gap down stocks ↗
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
These stocks that are showing activity before the opening bell on Wednesday. ↗
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Teradata Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
What's going on in today's after hours session ↗
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
A Look Ahead: Rigel Pharmaceuticals's Earnings Forecast ↗
 
Via Benzinga
News headline image
Rigel Pharmaceuticals Inc (NASDAQ:RIGL) Shows Strong Alignment with Navellier's Growth Criteria ↗
Rigel Pharmaceuticals shows explosive growth, strong cash flow, and high ROE, aligning with Louis Navellier's proven stock-picking system for growth investors. 
Via Chartmill
News headline image
RIGEL PHARMACEUTICALS INC (NASDAQ:RIGL) Combines Strong Growth and Bullish Technicals ↗
RIGL stock shows strong revenue & earnings growth with a low P/E ratio. Its technical chart pattern suggests a potential breakout from a recent trading range. 
Via Chartmill
News headline image
Rigel Pharmaceuticals Inc (NASDAQ:RIGL) Embodies the 'Affordable Growth' Investment Strategy ↗
Rigel Pharmaceuticals offers strong growth and earnings at an affordable valuation, making it a compelling candidate for the "Affordable Growth" investment strategy. 
Via Chartmill
News headline image
RIGEL PHARMACEUTICALS INC (NASDAQ:RIGL) Stands Out as a Top Growth Stock Candidate ↗
RIGL stock shows explosive growth with 5,567% EPS surge, soaring sales, and strong earnings surprises, fitting a proven growth investing model. 
Via Chartmill
News headline image
Rigel Pharmaceuticals Inc (NASDAQ:RIGL): An Affordable Growth Stock with Strong Upside Potential ↗
Rigel Pharmaceuticals (RIGL) offers high growth with a low P/E ratio. Strong EPS & revenue growth meet an affordable valuation, fitting the "affordable growth" investment profile. 
Via Chartmill
News headline image
Freeport-McMoRan, Harmony Biosciences, Cohu, And Other Big Stocks Moving Lower On Wednesday ↗
 
Via Benzinga
News headline image
Rigel Pharmaceuticals Inc (NASDAQ:RIGL) Identified as a Top Value Stock with Strong Fundamentals ↗
Rigel Pharmaceuticals (RIGL) is a biotech stock with a compelling valuation, trading at a low P/E ratio. It boasts strong profitability, exceptional revenue & EPS growth, and solid financial health. 
Via Chartmill
News headline image
Rigel Pharmaceuticals Inc (NASDAQ:RIGL) Shows Explosive Growth, Fits Navellier's 'Little Book' Strategy ↗
Rigel Pharmaceuticals shows explosive growth with 729% EPS growth, 106% revenue surge, and a 119% ROE, making it a top pick for momentum investors. 
Via Chartmill
News headline image
RIGEL PHARMACEUTICALS INC (NASDAQ:RIGL) Combines High Growth Momentum with Strong Technical Setup ↗
Discover RIGL stock's high growth momentum & strong technical setup. A top pick for investors seeking earnings acceleration & breakout potential. 
Via Chartmill
News headline image
Rigel Pharmaceuticals Inc (NASDAQ:RIGL) Emerges as a Top Affordable Growth Stock ↗
Rigel Pharmaceuticals (RIGL) is a GARP stock with explosive 729% EPS growth, trading at a deep discount with a P/E of just 7.11. 
Via Chartmill
News headline image
RIGEL PHARMACEUTICALS INC (NASDAQ:RIGL): A Deep Value Stock with Strong Fundamentals ↗
Rigel Pharmaceuticals (RIGL) presents a strong value investing case with a high valuation score, robust profitability, and impressive revenue growth, trading below intrinsic value. 
Via Chartmill
News headline image
Rigel Pharmaceuticals Inc (NASDAQ:RIGL) Emerges as a Top Growth Stock on Navellier's Screening Model ↗
Rigel Pharmaceuticals (RIGL) excels in a proven growth stock screening method, showing massive earnings growth, soaring revenue, and a high return on equity. 
Via Chartmill
News headline image
Argenx Stock Hits Record High After Reporting 664% Earnings Surge; This Rating Upgraded ↗
Additionally, the IBD SmartSelect Composite Rating for Argenx stock rose from 94 to a near best 96 Tuesday. 
Via Investor's Business Daily
Topics ETFs
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.